KLK3 and posterior cortical atrophy: Prostate-specific antigen (PSA) is generally used as an important clinical marker of early diagnosis, clinical stage, and postoperative observation for PCa because the PSA levels can rise before the presence of detectable PCa recurrence (Dall'oglio et al., 2005; Van Poppel et al., 2006).